We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

IBM Watson Turns Oncogenes Into Drug Targets

News   Aug 09, 2017 | Original story from Medical College of Georgia at Augusta University

 
IBM Watson Turns Oncogenes Into Drug Targets

Dr. Ravindra Kolhe, breast and molecular pathologist at the Medical College of Georgia at Augusta University

 
 
 

RELATED ARTICLES

New Genes Associated With the Leading Cause of Blindness

News

Researchers identify genes associated with Age-related Macular Degeneration (AMD) that could represent new targets for future drug development.

READ MORE

Illegal CRISPR Baby Scientist Scandal: Second Woman Is Pregnant

News

An investigation into gene edited human babies was recently conducted by a special team from Guangdong province.

READ MORE

Stem Cells Grown in Media Free of Animal-derived Compounds

News

Research team finds that mesenchymal progenitors can be grown without use of animal-derived compounds, a requirement for therapeutic applications.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE